Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion description "[Amplification of the CBFbeta/MYH11 fusion transcript by a qualitative reverse transcription-polymerase chain reaction (RT-PCR) has been used to detect minimal residual disease (MRD) and assess the risk for disease relapse in inv(16)(p13q22) acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion evidence source_evidence_literature NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion SIO_000772 11455976 NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion wasDerivedFrom befree-2016 NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion wasGeneratedBy ECO_0000203 NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- befree-2016 importedOn "2016-02-19" NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.